ZBIO - Zenas Biopharma Inc.
25.92
-0.220 -0.849%
Share volume: 323,598
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$26.14
-0.22
-0.01%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 11-12-2024 | 03-11-2025 | 05-15-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 10.000 M | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 10.000 M | 0.000 | |
| nan% | -100.00% | ||||
| Operating expenses | 40.984 M | 0.000 | 47.330 M | 52.580 M | |
| Selling general and admin | 7.454 M | 0.000 | 12.415 M | 13.178 M | |
| Research and development | 33.530 M | 0.000 | 34.915 M | 39.402 M | |
| Total expenses | 40.984 M | 0.000 | 47.330 M | 52.580 M | |
| -100.00% | 11.09% | ||||
| Operating income | -40.984 M | 0.000 | -37.330 M | -52.580 M | |
| Ebit | -38.606 M | 0.000 | -33.778 M | -51.499 M | |
| Pretax income | -38.606 M | 0.000 | -33.778 M | -51.499 M | |
| -100.00% | 52.46% | ||||
| Income tax | 0.000 | 0.000 | -205.000 K | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -38.606 M | 0.000 | -33.573 M | -51.499 M | |
| 100.00% | -53.39% |